Researchers have sequenced the parthenogenetic marbled crayfish, an invasive species, the Atlantic reports.
In Nature this week: genome analysis of citrus varieties, and more.
Natural History Museum researchers analyzed DNA from the 10,000-year-old 'Cheddar Man,' the Guardian reports.
Hospital pipes are a hotbed of antibiotic resistance genes, a new study has found.
Sema4 announces a new test to look for more diseases among newborn's genes, Technology Review reports.
In Cell this week: somatic cell nuclear transfer cloning of macaques, high-resolution yeast causal variant map, and more.
Personal Genome Project Canada reports its first wave of data, which includes some unexpected findings, the Globe and Mail writes.
A Memorial Sloan Kettering Cancer Center-led team has followed more than 50 patients for more than two years after receiving immunotherapy, Time reports.
The Huffington Post reports that a number of scientists are seeking political office this year.
In PNAS this week: variants influencing Alzheimer's disease, classification framework for tropical plants, and more.
Wired reports the World Anti-Doping Agency is weighing a proposal to require Olympic athletes to undergo genome sequencing.
The US National Institutes of Health has decided to discontinue PubMed Commons because of low uptake.
In PLOS this week: ramifications of sexual recombination in bacteria, Mycobacterium leprae genome sequences, and more.
UK regulators have approved the use of mitochondrial transfer in two cases, according to the Guardian.
Two bacterial species together help feed the development of colon cancer, according to the New York Times.
A Japanese research team has found a blood test that might be able to determine whether someone has early-stage Alzheimer's disease, Scientific American reports.
In Science this week: gene variant linked to inflammatory bowel disease, and more.
A Dutch famine during World War II led to life-long epigenetic changes in individuals whose mothers were pregnant with them at the time.
Marcelo Gleiser discusses our Last Universal Common Ancestor at NPR.
Technology Review reports that animals given large gene therapies doses have suffered fatal side effects.
In Nature this week: nanopore sequencing and assembly human genome, method to reduce CRISPR off-target effects, and more.
Brenda Fitzgerald, the director of the US Centers for Disease Control and Prevention, has stepped down, according to CNBC.
Synthetic Genomics is working on speeding up flu vaccine production, according to the San Diego Union-Tribune.
Bloomberg reports that many people are interested in genetic tests to refine their exercise regime and diet plan.
In Genome Research this week: guide RNAs to target KRAS mutations, modeling organ development from single cells, and more.
An analysis appearing in PeerJ finds that social media mentions of a paper may lead to increased citations.
NIH's Michael Lauer looks at the number of grants, their amount, and funding success rates at the agency for last year.
At Nature, Johns Hopkins' Gundula Bosch describes her graduate program that aims to get doctoral students thinking about the big picture.
Patricia Fara writes about childcare funding, and women in science and science history at NPR.